The trilogue agreement on New Genomic Techniques marks an important milestone in advancing innovation and strengthening the resilience of European agriculture.
The compromise agreement introduces certain aspects that remain unclear and will need thorough review to gauge their implications for day-to-day operations, compliance costs, and administrative requirements. Nevertheless, CropLife Europe acknowledges that the deal keeps innovation at its core.
The agreement broadly upholds the goal of establishing a supportive pathway for conventional-like NGT plants. This will help deliver crop varieties that are more resilient and better suited to today’s farming challenges, which is critical for the EU’s food security and competitiveness.
CropLife Europe remains committed to engaging with EU institutions to ensure effective implementation and to help unlock the full potential of NGTs for European agriculture and the broader agri-food chain.